Neoadjuvant Pembrolizumab plus Chemotherapy Versus Placebo plus Chemotherapy, Followed by Adjuvant Pembrolizumab Versus Placebo for Early-Stage Tnbc: Event-Free Survival Sensitivity and Subgroup Analyses from Keynote-522

AuthID
P-00X-FG9
30
Author(s)
Cortes, J
·
Dent, R
·
Pusztai, L
·
McArthur, H
·
Kummel, S
·
Bergh, J
·
Denkert, C
·
Park, YH
·
Hui, RN
·
[+10]·
Im, SA
·
Ahn, JH
·
Gion, M
·
Baron-Hay, S
·
Boileau, JF
·
Zhu, YL
·
Pan, W
·
Tryfonidis, K
·
Karantza, V
·
O'Shaughnessy, J
Tipo de Documento
Abstract
Year published
2022
Publicado
in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, ISSN: 1743-7555
Volume: 18, Páginas: 117-118 (2)
Indexing
Publication Identifiers
Wos: WOS:000871956500162
Source Identifiers
ISSN: 1743-7555
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Name Order Nome   Name Order Nome   Name Order Nome
1 Schmid, P;   2 Cortes, J;   3 Dent, R;
4 Pusztai, L;   5 McArthur, H;   6 Kummel, S;
7 Bergh, J;   8 Denkert, C;   9 Park, YH;
10 Hui, RN;   11 Harbeck, N;   12 Takahashi, M;
13 Untch, M;   14 Fasching, PA;   15 Cardoso, F;
16 Andersen, J;   17 Patt, D;   18 Danso, M;
19 Ferreira, M;   20 Mouret-Reynier, MA;   21 Im, SA;
22 Ahn, JH;   23 Gion, M;   24 Baron-Hay, S;
25 Boileau, JF;   26 Zhu, YL;   27 Pan, W;
28 Tryfonidis, K;   29 Karantza, V;   30 O'Shaughnessy, J;